Common use of Starting Date, Position, and Duties Clause in Contracts

Starting Date, Position, and Duties. a. Your initial position shall be Chief Financial Officer and SVP Business Development reporting to the Company’s CEO. We anticipate that your employment shall start effective no later than May 4, 2020 (the “Start Date”). b. As a member of our team, we expect you to devote all of your professional and working time and energies to the business and affairs of the Company. Notwithstanding the forgoing, nothing contained herein shall prevent you from managing your personal investments on your own personal time, including the right to make passive investments in the securities of: (i) any entity which you do not control, directly or indirectly, and which does not compete with Company, and (ii) any publicly held entity so long as your aggregate direct and indirect interest does not exceed five percent (5%) of the issued and outstanding securities of any class of securities of such publicly held entity. You shall not engage in other non-Company related business activities (including board memberships) without Company’s prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed. c. As is generally true for Company employees, you shall be employed on an at-will basis, which means that neither you nor the Company are guaranteeing this employment relationship for any specific period of time. Either of you or the Company may choose to end the employment relationship at any time, for any reason, with or without notice. The descriptions of benefits and other compensation arrangements set forth herein are meant to be summary in form and may be subject to change. Other than the terms of this Offer Letter, the Company reserves the right to alter, supplement or rescind its employment procedures, benefits or policies (other than the employment at-will policy) at any time in its sole and absolute discretion and without notice.

Starting Date, Position, and Duties. a. Your initial position shall be Chief Financial Scientific Officer and SVP Business Development reporting to the Company’s CEO. We anticipate that your employment shall start effective no later than May 4July 29, 2020 2019 (the “Start Date”). b. As a member of our team, we expect you to devote all of your professional and working time and energies to the business and affairs of the Company. Notwithstanding the forgoing, nothing contained herein shall prevent you from managing your personal investments on your own personal time, including the right to make passive investments in the securities of: (i) any entity which you do not control, directly or indirectly, and which does not compete with Company, and (ii) any publicly held entity so long as your aggregate direct and indirect interest does not exceed five percent (5%) of the issued and outstanding securities of any class of securities of such publicly held entity. You shall not engage in other non-Company related business activities (including board memberships) without Company’s prior written consent, which consent shall not be unreasonably withheld, conditioned or delayed. c. As is generally true for Company employees, you shall be employed on an at-will basis, which means that neither you nor the Company are guaranteeing this employment relationship for any specific period of time. Either of you or the Company may choose to end the employment relationship at any time, for any reason, with or without notice. The descriptions of benefits and other compensation arrangements set forth herein are meant to be summary in form and may be subject to change. Other than the terms of this Offer Letter, the Company reserves the right to alter, supplement or rescind its employment procedures, benefits or policies (other than the employment at-will policy) at any time in its sole and absolute discretion and without notice.

Starting Date, Position, and Duties. a. Your initial position shall be Chief Financial Officer and SVP Business Development reporting Scientific Officer. In your role, you shall report to the Company’s CEO. We anticipate that your employment shall start effective no later than May 4on December 10th, 2020 2019 (the “Start Date”). b. . In this key position you shall have responsibility for driving the scientific direction of the Company. In your role you are expected to build and supervise a team to execute against objectives and to develop and manage processes and systems to support these functions. It is understood that you will be employed by the Company in such capacity or such other capacity as may be mutually agreed upon by the Company and you from time to time. As a member of our team, we expect you to devote all of your professional and working time and energies to the business and affairs of the Company. Notwithstanding the forgoing, nothing contained herein shall prevent you from managing your personal investments on your own personal time, including the right to make passive investments in the securities of: (i) any entity which you do not control, directly or indirectly, and which does not compete with Company, and (ii) any publicly held entity so long as your aggregate direct and indirect interest does not exceed five percent (5%) of the issued and outstanding securities of any class of securities of such publicly held entity. You shall not engage in other non-Company related business activities (including board membershipsmemberships and academic appointments) without Company’s prior written consent, which provided that any such consented- to services do not interfere with the performance of your duties hereunder, do not compete with Company, and do not otherwise violate the provisions of your Confidentiality Agreement (as described below); and (ii) upon your request in advance of same, Company in its sole discretion may provide you with written consent shall to serve on other boards or committees (provided, again, that such consented-to services do not be unreasonably withheldinterfere with the performance of your duties hereunder, conditioned compete with Company, or delayedotherwise breach the provisions of your Confidentiality Agreement (as described below). c. b. As is generally true for Company employees, you shall be employed on an at-at- will basis, which means that neither you nor the Company are guaranteeing this employment relationship for any specific period of time. Either of you or the Company us may choose to end the employment relationship at any time, for any reason, with or without notice. The descriptions of benefits and other compensation arrangements set forth herein are meant to be summary in form and may be If any benefit is subject to changea benefit plan, the terms of that plan shall control. Other than the terms of this Offer Letter, the Company reserves the right to alter, supplement or rescind its employment procedures, benefits or policies (other than the employment at-will policy) at any time in its sole and absolute discretion and without notice.

Starting Date, Position, and Duties. a. Your initial position shall be Chief Financial Officer and SVP Business Development reporting Medical Officer. In your role, you shall report to the Company’s Chief Executive Officer of the Company (the “CEO”). We anticipate that your employment shall start effective no later than May 4on or before September 9th, 2020 2019 (the “Start Date”). b. . In this key position you shall have responsibility for leading and managing the clinical development, clinical operations, and regulatory-related interactions of the Company’s drug programs. In your role, you are expected to build and supervise a team in coordination with the CEO to execute against objectives and to develop and manage processes and systems to support these functions. It is understood that you will be employed by the Company in such capacity or such other capacity as may be mutually agreed upon by the Company and you from time to time. As a member of our team, we expect you to devote all of your professional and working time and energies to the business and affairs of the Company. Notwithstanding the forgoing, nothing contained herein shall prevent you from managing your personal investments on your own personal time, including the right to make passive investments in the securities of: (i) any entity which you do not control, directly or indirectly, and which does not compete with Company, and (ii) any publicly held entity so long as your aggregate direct and indirect interest does not exceed five percent (5%) of the issued and outstanding securities of any class of securities of such publicly held entity. You shall not engage in other non-Company related business activities (including consulting activities, board membershipsmemberships and academic appointments) without Company’s prior written consent, which Company may withhold in its sole discretion. Provided that you receive the Company’s consent to do so, your conduct of any such non-Company related business activities shall not be unreasonably withheldinterfere with the performance of your duties hereunder and shall not violate the provisions of your Confidentiality Agreement (as described below). For the avoidance of doubt, conditioned or delayedCompany does consent to you providing limited consulting services to your most-recent employer (“Former Employer”) until November 30, 2019 provided that such consulting services: (i) do not interfere with the performance of your duties hereunder; and (ii) do not violate the provisions of your Confidentiality Agreement. c. b. As is generally true for Company employees, you shall be employed on an at-at- will basis, which means that neither you nor the Company are guaranteeing this employment relationship for any specific period of time. Either of you or the Company us may choose to end the employment relationship at any time, for any reason, with or without notice. The descriptions of benefits and other compensation arrangements set forth herein are meant to be summary in form and may be If any benefit is subject to changea benefit plan, the terms of that plan shall control. Other than the terms of this Offer Letter, the Company reserves the right to alter, supplement or rescind its employment procedures, benefits or policies (other than the employment at-will policy) at any time in its sole and absolute discretion and without notice.